Atlas Trials

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

Clinical trial NCT01999803 · TERMINATED

Trial details

NCT number
NCT01999803
Sponsor
Newron Sweden AB
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Start date
2014-09-01
Primary completion
2015-10-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.